# reload+after+2024-01-20 01:46:03.140823
address1§Dorfstrasse 29
city§Zug
zip§6300
country§Switzerland
phone§41 415108022
website§https://www.moonlaketx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis. MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland.
fullTimeEmployees§20
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Jorge Santos da Silva', 'age': 45, 'title': 'Co-Founder, CEO & Director', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 1114564, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kristian  Reich', 'age': 57, 'title': 'Co-Founder & Chief Scientific Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 1202939, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Matthias  Bodenstedt', 'age': 35, 'title': 'Chief Financial Officer', 'yearBorn': 1988, 'fiscalYear': 2022, 'totalPay': 588245, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Oliver  Daltrop', 'title': 'Chief Technical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Nicolas  Mosimann', 'title': 'General Counsel', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Annett  Zippel', 'title': 'Director of People & Culture', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Nuala  Brennan', 'title': 'Chief Clinical Development Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.304
currency§USD
dateShortInterest§1702598400
forwardEps§-1.28
exchange§NCM
quoteType§EQUITY
shortName§MoonLake Immunotherapeutics
longName§MoonLake Immunotherapeutics
firstTradeDateEpochUtc§1603200600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e27878d5-f881-3e1b-8a06-8dc9330a65f3
gmtOffSetMilliseconds§-18000000
targetHighPrice§92.0
targetLowPrice§40.0
targetMeanPrice§69.25
targetMedianPrice§71.5
recommendationMean§1.6
recommendationKey§buy
numberOfAnalystOpinions§12
quickRatio§48.186
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
